|

Bexmarilimab 1mg/kg and nivolumab 1mg/kg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Institute of Cancer Research, United Kingdom1

Indications

  • Solid Tumor in Advanced Stage1
  • Melanoma (Skin Cancer)1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.